IDDI SYMPOSIUM - Are Randomized Clinical Trials Obsolete?

Clinical Trial Services for Biotech and Pharma companiesIDDI is abiostatisticalandeClinical servicesprovider offeringTrial Design-Randomization-Data ManagementandBiostatisticsservices for Pharmaceutical and Biotech companies.Combining Passion, Science and Experience to ensure your clinical data is ready for Submission

INTERNATIONAL DRUG DEVELOPMENT INSTITUTE - IDDI

This symposium will address the sources of bias that continue to threaten sound clinical research now and in the foreseeable future.

Auditorium Royal Museum of Fine Arts of Belgium

<h3>OUTLINE:</h3>April 2020 will mark the 40th anniversary of Jay Herson’s paper “Patient Registration in a Cooperative Oncology Group”. That paper, published in the first volume of the journal Controlled Clinical Trials, dealt with sources of bias and randomization practices that existed at the time. Looking back, it is surprising to see how much has changed since 1980. Whilst randomization remains a key design feature for confirmatory trials aimed at new drug approval, many innovative non-randomized study designs have been proposed and used in recent years.This symposium will address the sources of bias that continue to threaten sound clinical research now and in the foreseeable future. Past achievements and the current landscape will be described along with realistic proposals to move the field forward.<a href="https://www.iddi.com/news/news-events/symposium-are-randomized-trials-still-needed-in-2020/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer"> Read Symposium outline here.</a>CLICK ON THE GREEN BUTTON &#x27;TICKET&#x27; TO REGISTER.<h3>AGENDA</h3>09:00 - 09:30 – Welcome and Registration09:30 – 09:45 – Opening remarks – Marc Buyse, IDDI and U Hasselt, BelgiumSession 1 Laurence Collette, EORTC, Belgium, Moderator09:45 – 10:20 – KEYNOTE TALK 1: Bias and randomization: 1980 – 2020 – 2060 – Jay Herson, Johns Hopkins U, Baltimore, MD, USA10:20 – 10:45 – Innovative trial designs with and without randomization – François Beckers, Merck, Germany10:45 – 11:15 – Coffee break11:15 – 11:40 – Does precision medicine need randomized trials? – Everardo Saad, IDDI, Belgium11:40 – 12:05 – Can causal inference ever replace randomization? – Johan Steen, U Ghent, Belgium12:05 – 12:30 – Q &amp; A and discussion – Moderator and panelists12:30 – 13:45 – Lunch breakSession 2 Catherine Legrand, UCLouvain, Belgium, Moderator13:45 – 14:20 – KEYNOTE TALK 2: SOCRATES and the need for big randomized data – John Simes, NHMRC Clinical Trials Centre, Sydney, Australia14:20 – 14:45 – Pragmatic randomized trials – Frank Hulstaert, KCE, Belgium14:45 – 15:15 – Coffee breakSession 3 Bart Spiessens, Janssen R&amp;D, Belgium, Moderator15:15 – 15:50 – KEYNOTE TALK 3: Real-world evidence in medicines development and regulatory affairs: Applications and future directions – John O’Donnell, Bristol-Myers Squibb, Princeton, NJ, USA15:50 – 16:15 – The promise and perils of real-world evidence and big data – Tomasz Burzykowski, IDDI and U Hasselt, Belgium16:15 – 16:40 – Q &amp; A and discussion – Moderators and panelists17:00 – 19:00 – Networking Reception
More info on: <a href="https://www.iddi.com/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">WWW.IDDI.COM</a>We look forward to welcoming you! The IDDI Team

IDDI SYMPOSIUM - Are Randomized Clinical Trials Obsolete?

More events from INTERNATIONAL DRUG DEVELOPMENT INSTITUTE - IDDI

Discover more events from INTERNATIONAL DRUG DEVELOPMENT INSTITUTE - IDDI, from Science & Tech to other experiences you might love.

IDDI SYMPOSIUM - Are Randomized Clinical Trials Obsolete?

More events from INTERNATIONAL DRUG DEVELOPMENT INSTITUTE - IDDI

Discover more events from INTERNATIONAL DRUG DEVELOPMENT INSTITUTE - IDDI, from Science & Tech to other experiences you might love.

You might also like...

Browse more events with different dates, prices, and formats to find your next great experience.